Status:
UNKNOWN
Spinal Cord Stimulation for Neuropathic Pain Relief : Efficacy Study Using the Specific NPSI Questionnaire (NPSI)
Lead Sponsor:
Hopital Foch
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18+ years
Brief Summary
Several studies have shown the efficacy of spinal cord stimulation in reducing the intensity of neuropathic pain. This efficacy is defined as obtaining relief of at least 50% of the preoperative pain ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- With neuropathic pain:
- confirmed (DN4 score\> 4/10)
- going back to one year at least
- refractory to well-conducted medical treatments
- Requiring spinal cord stimulation: the indication is validated by the multidisciplinary meeting (RCP Neuromodulation / Pain at Foch Hospital)
- Having given his non-opposition
Exclusion
- Patient with sepsis
- Having no well-conducted prior medical treatment
- With uncontrolled psychiatric disorders (active psychosis, suicidal disorders, severe depression)
- with somatoform disorders
- addicted to alcohol or drugs or withdrawal syndrome
- Deprived of liberty or under guardianship.
Key Trial Info
Start Date :
October 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 19 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04470206
Start Date
October 19 2020
End Date
December 19 2023
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Foch
Suresnes, Île-de-France Region, France, 92500